NCT03951337View on ClinicalTrials.gov

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 26, 2019

Primary Completion Date

July 31, 2024

Study Completion Date

January 31, 2026

Conditions
Rectal Cancer
Interventions
DRUG

64Cu-ATSM

64 Cu-ATSM PET/CT scan

Trial Locations (5)

29200

CHU de BREST, Brest

35045

Centre Eugene Marquis, Rennes

44805

Institut de cancerologie de l'Ouest, Saint-Herblain

49055

Institut de Cancerologie de l'Ouest (ICO), Angers

76038

Centre Henri Becquerel, Rouen

All Listed Sponsors
collaborator

Fondation ARC

OTHER

lead

Institut Cancerologie de l'Ouest

OTHER

NCT03951337 - 64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum) | Biotech Hunter | Biotech Hunter